Globally, one in three women and one in five men over age 50 will experience an osteoporosis-related fracture during their remaining lifetimes. As of 2024, vitamin D deficiency remains a significant global health concern, with implications for bone health and fracture risk. Muscle weakness contributes to 19% of premature deaths after fractures in women and 27% in men. In the setting of Vitamin D deficiency in hip fracture patients have associated increased mortality risk, hence the importance of maintaining adequate vitamin D levels in vulnerable populations, musculoskeletal training and lifestyle intervention to prevent fractures and osteoporosis. More education and training is needed to create awareness of these public health issues.  

Fractures and muscle weakness are interrelated, especially in older adults. Maintaining muscle strength is crucial for reducing fracture risk and improving post-fracture outcomes. Osteomalacia and vitamin D deficiency are contributing factors that need to be evaluated when treating Osteoporosis. Providers need up-to-date knowledge on when supplementation or pharmacologic treatments (like bisphosphonates) are appropriate.